Live

The Marseille Cancer Research Center celebrates its 50th anniversary ! -

Aug 2019 Chemical communications (Cambridge, England)

Flavonoid-alkylphospholipid conjugates elicit dual inhibition of cancer cell growth and lipid accumulation.

Authors

Zhou Z, Luo B, Liu X, Chen M, Lan W, Iovanna JL, Peng L, Xia Y

Summary

Cancer development is often associated with lipid metabolic reprogramming, including aberrant lipid accumulation. We create novel paradigms endowed with dual functions of anticancer activity and inhibition of lipid accumulation by conjugating the natural product quercetin and synthetic alkylphospholipid drugs, and harnessing the biomedical effects of both. These conjugates offer fresh perspectives in the search for anticancer candidates.

Read the article